For citations:
Chazova I.E., Martynyuk T.V., Rodnenkov O.V., Gorieva S.B., Rogoza A.N., Arkhipov M.V., Grinshtein Y.I., Ostroumova O.D., Galyavich A.S., Rotar’ O.P., Khaisheva L.A., Kameneva T.R. Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II. Systemic Hypertension. 2021;18(1):50-62. (In Russ.) https://doi.org/10.26442/2075082X.2021.1.200736
Email this article 